Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Milestone Pharmaceuticals Inc. (MIST)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17
   10-K10-K10-K10-K/AS-1/A
Revenues  15.0-5.9-8.9-3.98.3
            Revenue growth  -352.7%-33.2%126.8%-147.4% 
Cost of goods sold  7.00.00.00.08.3
Gross profit  8.0-5.9-8.9-3.90.0
            Gross margin  53.3%100.0%100.0%100.0%0.0%
Selling, general and administrative   [+]12.410.37.03.11.5
Research and development  38.734.542.016.8 
Other operating expenses      6.8
EBITDA   [+]-43.0-50.6-57.8-23.8-8.3
            EBITDA margin  -286.5%852.5%650.5%607.3%-99.9%
Depreciation and amortization  0.10.10.00.00.0
EBIT   [+]-43.1-50.7-57.9-23.8-8.3
            EBIT margin  -287.2%854.1%650.9%607.5%-100.0%
Interest income  0.20.72.60.7 
Other income (expense), net      8.3
Pre-tax income  -42.9-50.0-55.3-23.10.0
Income taxes  0.00.0-0.10.10.0
            Tax rate  0.0%0.0%0.1%  
Net income  -42.9-50.0-55.2-23.20.0
            Net margin  -285.7%841.6%621.1%591.3%0.0%
   
Basic EPS   [+]($1.02)($1.70)($3.50)($72.63) 
Diluted EPS   [+]($1.02)($1.70)($3.50)($72.63) 
   
Shares outstanding (basic)   [+]42.029.415.80.3 
Shares outstanding (diluted)   [+]42.029.415.80.3 
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy